News & Media
Newsroom
New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes
10.28.2025
Full Release
SK Life Science, Inc. to Host “Illuminating the Path to Added Seizure Reduction” Symposium at the 2025 American Epilepsy Society Annual Meeting
10.24.2025
Full Release
SK Biopharmaceuticals to Launch JV with Eurofarma in US for AI Digital Health Solutions
06.18.2025
Full Release
Welcome to the news and information center for SK Life Science, Inc.
To learn more about SK Life Science, please download our corporate brochure
For more information about epilepsy, please download this infographic
To view the Hope, Hesitancy, and Hard Truths survey report, please click here.
Please see report infographic below
SK Life Science at a Glance
Headquarters Location: Paramus, NJ
Parent Company: SK Life Science is a subsidiary of SK Biopharmaceuticals, Co., Ltd, and both are part of SK Group
Number of Employees: 200+ Employees
Disease Category Focus: CNS Disorders and Oncology
Pipeline: 12 compounds under clinical development